ASH 2018: Machine learning-based model improves prognosis accuracy for myelodysplastic syndromes
Researchers have presented at ASH 2018 in San Diego the model of using machine learning – a…
Browsing: AML
91 percent response rate for venetoclax against newly diagnosed AML in older adults
Clinical trial results published in the journal Nature Medicine show 91 percent response rate to the combination…
DNA test for predicting risk of leukaemia relapse
A group of Canadian and Korean scientists and physicians have developed the first DNA-based test…
Increased risk of myeloid blood cancers in relatives of patients
The largest ever study of its type is the first to definitively show an increased…
Taming a fatal blood cancer
When a dangerous defect on chromosome 11q23 disrupts the genetic programming of blood cells, it…
New CAR T case study shows promise in acute myeloid leukaemia
Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest…
Throwing molecular wrench into gene control machine leads to ‘melting away’ of leukaemia
Cancer researchers today announced they have developed a way of sidelining one of the most…
Unforeseen new drug target discovered for acute myeloid leukaemia
A study has found an unexpected new drug target for acute myeloid leukaemia (AML) that…
Stealing from the body: How cancer recharges its batteries
New research uncovers how the blood cancer ‘steals’ parts of surrounding healthy bone marrow cells…
Combination approach improves power of new cancer therapy
An international research team has found a way to improve the anti-cancer effect of a…